Application 212086
- Type
- ANDA
- Sponsor
- FRESENIUS KABI USA
Application Products#
Product, Drug, Ingredient table| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|
| 001 | FENTANYL CITRATE | FENTANYL CITRATE | INJECTABLE;INJECTION | EQ 0.05MG BASE/ML | No | No |
NDC Listings For This Application#
NDC, Name, Nonproprietary name table| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|
| 63323-808 | Fentanyl Citrate | Fentanyl Citrate | Fresenius Kabi USA, LLC | ANDA | Current |
| 63323-817 | Fentanyl Citrate | Fentanyl Citrate | Fresenius Kabi USA, LLC | ANDA | Current |